ArticleSkin health and disease2021

Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma.

M K Ramirez-Fort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.